Litcius/Paper detail

Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis

Meng‐Chuan Wang

2023Heliyon27 citationsDOIOpen Access PDF

Abstract

Pulmonary fibrosis is an enduring and advancing pulmonary interstitial disease caused by multiple factors that ultimately lead to structural changes in normal lung tissue. Currently, pulmonary fibrosis is a global disease with a high degree of heterogeneity and mortality rate. Nitidine and pirfenidone have been approved for treating pulmonary fibrosis, and the quest for effective therapeutic drugs remains unabated. In recent years, the anti-pulmonary fibrosis properties of natural flavonoids have garnered heightened attention, although further research is needed. In this paper, the resources, structural characteristics, anti-pulmonary fibrosis properties and mechanisms of natural flavonoids were reviewed. We hope to provide potential opportunities for the application of flavonoids in the fight against pulmonary fibrosis.

Topics & Concepts

PirfenidonePulmonary fibrosisMedicinePulmonary diseaseIdiopathic pulmonary fibrosisFibrosisLungDiseaseIntensive care medicinePathologyInternal medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisRespiratory and Cough-Related ResearchPulmonary Hypertension Research and Treatments